TY - JOUR
T1 - Design of a multiplex ligation-dependent probe amplification assay for SLC20A2
T2 - identification of two novel deletions in primary familial brain calcification
AU - Giorgio, Elisa
AU - Garelli, Emanuela
AU - Carando, Adriana
AU - Bellora, Stefania
AU - Rubino, Elisa
AU - Quarello, Paola
AU - Sirchia, Fabio
AU - Marrama, Federico
AU - Gallone, Salvatore
AU - Grosso, Enrico
AU - Pasini, Barbara
AU - Massa, Roberto
AU - Brussino, Alessandro
AU - Brusco, Alfredo
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Primary familial brain calcification (PFBC) is a rare disease characterized by brain calcifications that mainly affect the basal ganglia, thalamus, and cerebellum. Among the four autosomal-dominant genes known to be associated with the disease, SLC20A2 pathogenic variants are the most common, accounting for up to 40% of PFBC dominant cases; variants include both point mutations, small insertions/deletions and intragenic deletions. Over the last 7 years, we have collected a group of 50 clinically diagnosed PFBC patients, who were screened for single nucleotide changes and small insertions/deletions in SLC20A2 by Sanger sequencing. We found seven pathogenic/likely pathogenic variants: four were previously described by our group, and three are reported here (c.303delG, c.21delG, and c.1795-1G>A). We developed and validated a synthetic Multiplex Ligation-dependent Probe Amplification (MLPA) assay for SLC20A2 deletions, covering all ten coding exons and the 5′ UTR (SLC20A2-MLPA). Using this method, we screened a group of 43 PFBC-patients negative for point mutations and small insertions/deletions, and identified two novel intragenic deletions encompassing exon 6 NC_000008.10:g.(42297172_42302163)_(423022281_42317413)del, and exons 7–11 including the 3′UTR NC_000008.10:g.(?_42275320)_(42297172_42302163)del. Overall, SLC20A2 deletions may be highly underestimated PFBC cases, and we suggest MLPA should be included in the routine molecular test for PFBC diagnosis.
AB - Primary familial brain calcification (PFBC) is a rare disease characterized by brain calcifications that mainly affect the basal ganglia, thalamus, and cerebellum. Among the four autosomal-dominant genes known to be associated with the disease, SLC20A2 pathogenic variants are the most common, accounting for up to 40% of PFBC dominant cases; variants include both point mutations, small insertions/deletions and intragenic deletions. Over the last 7 years, we have collected a group of 50 clinically diagnosed PFBC patients, who were screened for single nucleotide changes and small insertions/deletions in SLC20A2 by Sanger sequencing. We found seven pathogenic/likely pathogenic variants: four were previously described by our group, and three are reported here (c.303delG, c.21delG, and c.1795-1G>A). We developed and validated a synthetic Multiplex Ligation-dependent Probe Amplification (MLPA) assay for SLC20A2 deletions, covering all ten coding exons and the 5′ UTR (SLC20A2-MLPA). Using this method, we screened a group of 43 PFBC-patients negative for point mutations and small insertions/deletions, and identified two novel intragenic deletions encompassing exon 6 NC_000008.10:g.(42297172_42302163)_(423022281_42317413)del, and exons 7–11 including the 3′UTR NC_000008.10:g.(?_42275320)_(42297172_42302163)del. Overall, SLC20A2 deletions may be highly underestimated PFBC cases, and we suggest MLPA should be included in the routine molecular test for PFBC diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=85072687169&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072687169&partnerID=8YFLogxK
U2 - 10.1038/s10038-019-0668-3
DO - 10.1038/s10038-019-0668-3
M3 - Article
C2 - 31501477
AN - SCOPUS:85072687169
VL - 64
SP - 1083
EP - 1090
JO - Journal of Human Genetics
JF - Journal of Human Genetics
SN - 1434-5161
IS - 11
ER -